• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对一种高度糖基化蛋白的单克隆抗体在固定组织中与黑色素瘤及其他肿瘤发生反应。

Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors.

作者信息

Atkinson B, Ernst C S, Ghrist B F, Ross A H, Clark W H, Herlyn M, Herlyn D, Maul G, Steplewski Z, Koprowski H

出版信息

Hybridoma. 1985 Fall;4(3):243-55. doi: 10.1089/hyb.1985.4.243.

DOI:10.1089/hyb.1985.4.243
PMID:4043988
Abstract

A highly glycosylated protein with a molecular weight of 30,000 to 60,000 and a protein core of 20,000 daltons has been identified by antimelanoma monoclonal antibodies. The antigenicity of this melanoma-associated glycoprotein (MAG) was not destroyed in fixed paraffin-embedded melanoma tissue, and was present in malignant cells of cutaneous superficial spreading melanomas in skin (31/33) and in half of all metastatic melanomas examined (5/10). The antigen was not expressed by normal melanocytes. The strong reactivity of dysplastic nevi with the anti-MAG antibodies was comparable to that seen in radial growth phase melanoma. Antigen expression was much weaker in compound nevi where reactivity ranged from moderate in the junctional component and the upper dermis to absent at the base of the nevus.

摘要

抗黑色素瘤单克隆抗体已识别出一种高度糖基化的蛋白质,其分子量为30,000至60,000,蛋白质核心为20,000道尔顿。这种黑色素瘤相关糖蛋白(MAG)的抗原性在固定的石蜡包埋黑色素瘤组织中未被破坏,并且存在于皮肤浅表扩散性黑色素瘤的恶性细胞中(31/33)以及所检查的所有转移性黑色素瘤的一半中(5/10)。正常黑素细胞不表达该抗原。发育异常痣与抗MAG抗体的强反应性与在放射状生长期黑色素瘤中所见相当。在复合痣中抗原表达要弱得多,其反应性在交界成分和真皮上层为中度,在痣底部则不存在。

相似文献

1
Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors.针对一种高度糖基化蛋白的单克隆抗体在固定组织中与黑色素瘤及其他肿瘤发生反应。
Hybridoma. 1985 Fall;4(3):243-55. doi: 10.1089/hyb.1985.4.243.
2
Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.人类黑素细胞痣和黑色素瘤肿瘤进展阶段的抗原特征
Cancer Res. 1989 Sep 15;49(18):5091-6.
3
Tumor antigen expression in compound dysplastic nevi and superficial spreading melanoma defined by a panel of nevomelanoma monoclonal antibodies.通过一组痣黑素瘤单克隆抗体定义的复合发育异常痣和浅表扩散性黑素瘤中的肿瘤抗原表达
Hybridoma. 1996 Apr;15(2):141-6. doi: 10.1089/hyb.1996.15.141.
4
Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.通过两种新型抗原(一种分子量为113,000的糖蛋白和一种分子量为76,000的蛋白质)区分黑素细胞系的良性和恶性细胞。
Cancer Res. 1987 Feb 1;47(3):841-5.
5
Identification of a secreted Mr 95,000 glycoprotein in human melanocytes and melanomas by a melanocyte specific monoclonal antibody.利用一种黑素细胞特异性单克隆抗体鉴定人黑素细胞和黑色素瘤中一种分泌型95000分子量糖蛋白。
Cancer Res. 1988 Mar 1;48(5):1286-94.
6
A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells.一种由人类黑色素瘤和癌细胞表达的94,000道尔顿糖蛋白。
J Natl Cancer Inst. 1982 May;68(5):761-9.
7
Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.由小鼠单克隆抗体定义的黑色素瘤和黑色素细胞的表面抗原:培养细胞和组织中抗原表达的特异性分析与比较
Cancer Res. 1985 Sep;45(9):4401-11.
8
A monoclonal antibody specific for cells of the melanocyte lineage.一种对黑素细胞谱系细胞具有特异性的单克隆抗体。
Am J Pathol. 1988 Jan;130(1):179-92.
9
Human monoclonal antibodies that distinguish cutaneous malignant melanomas from benign nevi in fixed tissue sections.可在固定组织切片中区分皮肤恶性黑色素瘤与良性痣的人源单克隆抗体。
J Invest Dermatol. 1986 Feb;86(2):145-8. doi: 10.1111/1523-1747.ep12284184.
10
Use of monoclonal antibodies in detection of melanoma-associated antigens in intact human tumors.单克隆抗体在完整人类肿瘤中检测黑色素瘤相关抗原的应用。
Am J Pathol. 1982 Jun;107(3):357-61.

引用本文的文献

1
Tetraspanin CD63 reduces the progression and metastasis of head and neck squamous cell carcinoma via KRT1-mediated cell cycle arrest.四跨膜蛋白CD63通过KRT1介导的细胞周期阻滞减少头颈部鳞状细胞癌的进展和转移。
Heliyon. 2023 Jul 4;9(7):e17711. doi: 10.1016/j.heliyon.2023.e17711. eCollection 2023 Jul.
2
Tetraspanins and tumor progression.四跨膜蛋白与肿瘤进展。
Clin Exp Metastasis. 2011 Mar;28(3):261-70. doi: 10.1007/s10585-010-9365-5. Epub 2010 Dec 24.
3
Down-regulation of CD9 expression and its correlation to tumor progression in B lymphomas.
CD9 表达下调及其与 B 细胞淋巴瘤肿瘤进展的相关性。
Am J Pathol. 2010 Jul;177(1):377-86. doi: 10.2353/ajpath.2010.100048. Epub 2010 Jun 21.
4
Deficiency of the tetraspanin CD63 associated with kidney pathology but normal lysosomal function.四跨膜蛋白CD63缺乏与肾脏病理相关,但溶酶体功能正常。
Mol Cell Biol. 2009 Feb;29(4):1083-94. doi: 10.1128/MCB.01163-08. Epub 2008 Dec 15.
5
Protein kinase activity is associated with CD63 in melanoma cells.蛋白激酶活性与黑色素瘤细胞中的CD63相关。
J Transl Med. 2005 Nov 30;3:42. doi: 10.1186/1479-5876-3-42.
6
Isolation of a novel cDNA clone showing marked similarity to ME491/CD63 superfamily.一个与ME491/CD63超家族具有显著相似性的新型cDNA克隆的分离。
Immunogenetics. 1993;37(3):193-8. doi: 10.1007/BF00191884.
7
Differences in antigen expression between neoplastic and nonneoplastic gallbladder epithelium. An immunohistochemical study.肿瘤性与非肿瘤性胆囊上皮之间抗原表达的差异。一项免疫组织化学研究。
Dig Dis Sci. 1993 Jan;38(1):155-60. doi: 10.1007/BF01296789.
8
Growth and invasion of human melanomas in human skin grafted to immunodeficient mice.人黑色素瘤在移植到免疫缺陷小鼠的人皮肤中的生长与侵袭。
Am J Pathol. 1993 Aug;143(2):528-37.
9
Transcriptional enhancement of the human gene encoding for a melanoma-associated antigen (ME491) in association with malignant transformation.与恶性转化相关的人类黑色素瘤相关抗原(ME491)编码基因的转录增强。
Jpn J Cancer Res. 1989 Dec;80(12):1186-91. doi: 10.1111/j.1349-7006.1989.tb01653.x.
10
Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3.通过单克隆抗体NKI/C-3检测到的循环黑色素瘤相关抗原。
Cancer Immunol Immunother. 1986;23(2):93-100. doi: 10.1007/BF00199813.